United Health Products, Inc. provided an update on the company's FDA Premarket Approval application process. The company confirms that it has submitted via the FDA eSTAR portal its Premarket Approval application for its absorbable hemostatic gauze, which will now be reviewed by the FDA and Health Canada. There can be no assurance that the company's PMA or Health Canada applications will be approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | -1.10% | -11.07% | -18.18% |
Apr. 01 | United Health Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | United Health Products Submits Full FDA PMA Application | CI |
1st Jan change | Capi. | |
---|---|---|
-18.18% | 44.57M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.01B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- UEEC Stock
- News United Health Products, Inc.
- United Health Products Submits Full FDA PMA Application